167 related articles for article (PubMed ID: 10684168)
1. [Anti glomerular basement membrane disease in a renal transplant patient with Alport syndrome].
Soler Pujol G; Iotti R; Dávalos Michel M; Turner AN; Vilches AR
Medicina (B Aires); 1999; 59(5 Pt 1):466-8. PubMed ID: 10684168
[TBL] [Abstract][Full Text] [Related]
2. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
3. Kidney transplantation in patients with alport syndrome.
Mojahedi MJ; Hekmat R; Ahmadnia H
Urol J; 2007; 4(4):234-7. PubMed ID: 18270949
[TBL] [Abstract][Full Text] [Related]
4. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
Brainwood D; Kashtan C; Gubler MC; Turner AN
Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
[TBL] [Abstract][Full Text] [Related]
5. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome.
Charytan D; Torre A; Khurana M; Nicastri A; Stillman IE; Kalluri R
J Nephrol; 2004; 17(3):431-5. PubMed ID: 15365966
[TBL] [Abstract][Full Text] [Related]
6. Outcome of renal transplantation in Alport's syndrome: a single-center experience.
Gumber MR; Kute VB; Goplani KR; Vanikar AV; Shah PR; Patel HV; Trivedi HL
Transplant Proc; 2012 Jan; 44(1):261-3. PubMed ID: 22310627
[TBL] [Abstract][Full Text] [Related]
7. Anti-glomerular and anti-tubular basement membrane nephritis in a renal allograft recipient with Alport's syndrome.
Diaz JI; Valenzuela R; Gephardt G; Novick A; Tubbs RR
Arch Pathol Lab Med; 1994 Jul; 118(7):728-31. PubMed ID: 8024409
[TBL] [Abstract][Full Text] [Related]
8. Late presentation of Alport posttransplantation anti-glomerular basement membrane disease.
de Sandes-Freitas TV; Holanda-Cavalcanti A; Mastroianni-Kirsztajn G; Franco MF; Medina-Pestana JO
Transplant Proc; 2011 Dec; 43(10):4000-1. PubMed ID: 22172887
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
10. [Cadaveric renal transplantation for Goodpasture's syndrome: a case report].
Miyazato M; Koyama Y; Miyazato T; Yonou H; Naito A; Sugaya K; Hatano T; Ogawa Y
Hinyokika Kiyo; 2001 Jul; 47(7):493-5. PubMed ID: 11523135
[TBL] [Abstract][Full Text] [Related]
11. [Goodpasture syndrome: treatment initiation with plasmapheresis before histologic diagnostic verification].
Gartenschläger M; Lenci G; Schinzel H; Schweden F; Dienes HP; Weilemann LS
Pneumologie; 1996 Nov; 50(11):764-8. PubMed ID: 9082444
[TBL] [Abstract][Full Text] [Related]
12. Kidney transplantation in Alport's syndrome: long-term outcome and allograft anti-GBM nephritis.
Göbel J; Olbricht CJ; Offner G; Helmchen U; Repp H; Koch KM; Frei U
Clin Nephrol; 1992 Dec; 38(6):299-304. PubMed ID: 1468159
[TBL] [Abstract][Full Text] [Related]
13. [Anti-basal membrane glomerulonephritis after homologous kidney transplantation in hereditary Alport's nephropathy].
Bach D; Peters A; Röwemeier H; Degenhardt S; Helmchen U; Grabensee B
Dtsch Med Wochenschr; 1991 Nov; 116(46):1752-6. PubMed ID: 1935663
[TBL] [Abstract][Full Text] [Related]
14. Renal transplant in patients with Alport's syndrome.
Byrne MC; Budisavljevic MN; Fan Z; Self SE; Ploth DW
Am J Kidney Dis; 2002 Apr; 39(4):769-75. PubMed ID: 11920343
[TBL] [Abstract][Full Text] [Related]
15. Retransplantation in Alport post-transplant anti-GBM disease.
Browne G; Brown PA; Tomson CR; Fleming S; Allen A; Herriot R; Pusey CD; Rees AJ; Turner AN
Kidney Int; 2004 Feb; 65(2):675-81. PubMed ID: 14717941
[TBL] [Abstract][Full Text] [Related]
16. Autotopes and allotopes.
Kashtan C
J Am Soc Nephrol; 2005 Dec; 16(12):3455-7. PubMed ID: 16251234
[No Abstract] [Full Text] [Related]
17. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
[TBL] [Abstract][Full Text] [Related]
18. Loss of a renal graft due to recurrence of anti-GBM disease despite rituximab therapy.
Sauter M; Schmid H; Anders HJ; Heller F; Weiss M; Sitter T
Clin Transplant; 2009; 23(1):132-6. PubMed ID: 19087095
[TBL] [Abstract][Full Text] [Related]
19. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
Chen N; Pan X; Ren H; Dong D
Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
[TBL] [Abstract][Full Text] [Related]
20. [Goodpasture disease].
Fomegné G; Dratwa M; Wens R; Mesquita M; Van der Straaten M; Vanden Haute K; Fosso C
Rev Med Brux; 2006; 27(3):162-6. PubMed ID: 16894954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
